Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZYMERGEN INC.

(ZY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Certain Stock Options of Zymergen Inc. are subject to a Lock-Up Agreement Ending on 19-OCT-2021.

10/19/2021 EST

Certain Stock Options of Zymergen Inc. are subject to a Lock-Up Agreement Ending on 19-OCT-2021. These Stock Options will be under lockup for 181 days starting from 21-APR-2021 to 19-OCT-2021. Details: The directors, executive officers and holders of substantially all of the capital stock and securities convertible into capital stock (such persons, the “lock-up parties”) have entered or will enter into lock-up agreements with the underwriters prior to the commencement of this offering pursuant to which each of these persons or entities, with limited exceptions, for a period of 180 days after the date of this prospectus, may not (and may not cause any of their direct or indirect affiliates to), without the prior written consent of J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC to offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any shares of common stock or any securities convertible into or exercisable or exchangeable for common stock.


© S&P Capital IQ 2021
All news about ZYMERGEN INC.
12/03ZYMERGEN ALERT : Bragar Eagel & Squire, P.C. Is Investigating Zymergen Inc. on Behalf of L..
BU
11/22INSIDER BUY : Zymergen
MT
11/15ZYMERGEN INC. Management's Discussion and Analysis of Financial Condition and Results ..
AQ
11/11The Law Offices of Frank R. Cruz Announces Investigation of Zymergen Inc. (ZY) on Behal..
BU
11/10Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigati..
BU
11/03ZYMERGEN : Q3 Earnings Snapshot
AQ
11/03Zymergen Reports Preliminary Third Quarter 2021 Financial Results and Provides Business..
PU
11/03Earnings Flash (ZY) ZYMERGEN Reports Q3 Revenue $4.1M, vs. Street Est of $3.41M
MT
11/03Zymergen Reports Preliminary Third Quarter 2021 Financial Results and Provides Business..
AQ
10/26Zymergen to Report Third Quarter 2021 Financial Results on November 3, 2021
GL
More news
Analyst Recommendations on ZYMERGEN INC.
More recommendations
Financials (USD)
Sales 2021 16,5 M - -
Net income 2021 -372 M - -
Net cash 2021 309 M - -
P/E ratio 2021 -1,66x
Yield 2021 -
Capitalization 780 M 780 M -
EV / Sales 2021 28,6x
EV / Sales 2022 39,8x
Nbr of Employees 758
Free-Float 90,7%
Chart ZYMERGEN INC.
Duration : Period :
Zymergen Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZYMERGEN INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 7
Last Close Price 7,62 $
Average target price 9,50 $
Spread / Average Target 24,7%
EPS Revisions
Managers and Directors
Jay T. Flatley Chairman & Chief Executive Officer
Enakshi Singh Chief Financial Officer
Zachariah Serber Director & Chief Science Officer
Jed Dean Vice President-Operations & Engineering
Aaron Kimball Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
ZYMERGEN INC.0.00%780
SHIN-ETSU CHEMICAL CO., LTD.7.12%70 989
BASF SE-8.71%60 548
DUPONT DE NEMOURS, INC.6.15%39 106
ROYAL DSM N.V.35.16%36 632
PIDILITE INDUSTRIES LIMITED25.22%14 933